Rocket Lab is stepping on the gas. With eight launches already completed this year, the company is barreling toward its own annual record and the milestone of its 100th orbital mission. The coming days alone will test that momentum: a hypersonic test flight from Virginia’s Wallops Flight Facility on Thursday, followed by a dedicated Electron launch from New Zealand on June 17 for Japanese satellite operator Synspective — its tenth mission for that client.
The operational cadence is more than a technical showcase. Chief executive Peter Beck has repeatedly argued that only two companies on the planet deliver reliable, high-frequency orbital launches: SpaceX and Rocket Lab. That duopoly narrative is now drawing fresh attention from investors, as the sector braces for SpaceX’s long-awaited initial public offering, expected on June 12 with an eye-watering valuation of 1.77 trillion US dollars.
Record Revenue, but the Engine Room Is Space Systems
The numbers behind the hype are stacking up. Rocket Lab posted first-quarter 2026 revenue of $200.3 million — a 63.5% jump year-over-year — driven largely by its Space Systems segment, which alone brought in $136.7 million. That’s more than double the $63.7 million generated by launch services. The total backlog has swelled to $2.2 billion, matched only by the company’s market capitalization of $68.8 billion at the current share price of $113.80, which has gained 316% over the past twelve months.
Management sees the pace continuing. Second-quarter guidance stands at $225 million to $240 million in revenue, fueled by a pipeline of contracts that includes an $816 million award from the Space Development Agency for missile-tracking satellites and a $90 million U.S. Space Force deal for two geostationary satellites equipped with the Heimdall surveillance system — Rocket Lab’s first foray into the GEO segment.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
Balancing the Books and the Boardroom
While the topline climbs, the bottom line remains a work in progress. Free cash flow is still negative as the company pours investment into its next-stage rocket, Neutron, a reusable medium-lift vehicle whose first launch is slated for 2026. Financial chief Adam Spice, meanwhile, is expanding his own orbit: he has joined the board of AI specialist Syntiant, where he will help scale its financial operations — a move that aligns with Rocket Lab’s broader push to embed autonomous systems into its space business.
The operational highlights are not without reminders of the cost of expansion. The stock is trading roughly 25% below its all-time high of $151, reached in late May. That peak came during a broader sector correction at the end of May, from which space equities have since recovered on a wave of institutional interest. Thursday’s hypersonic flight — dubbed “Curveball” and flying the HASTE variant of Electron — will serve as the next operational proof point.
The Neutron Event Horizon
Beyond the near-term launches, the Neutron rocket represents the most significant inflection point on Rocket Lab’s roadmap. The company has completed engine tests and initial structural milestones, and it expects the vehicle to unlock heavier payloads and new customer segments. The acquisition of Motiv Space Systems, which brings Mars-proven robotics technology, further strengthens the internal capabilities needed to support that ambition.
CEO Peter Beck has been candid about the timeline: profitability is not expected before 2027. For now, investors buying Rocket Lab are buying a growth program — one that runs on a dual fuel of record revenue and a tailwind from the most anticipated IPO in the space industry’s history. The countdown to Thursday’s launch and to SpaceX’s market debut is ticking in parallel.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from June 9 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 9.
Rocket Lab USA: Buy or sell? Read more here...








